nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—CYP1A2—Clobetasol propionate—psoriasis	0.168	0.232	CbGbCtD
Dopamine—CYP1A2—Methoxsalen—psoriasis	0.0882	0.122	CbGbCtD
Dopamine—CYP2D6—Hydroxyurea—psoriasis	0.0795	0.11	CbGbCtD
Dopamine—CYP2C19—Cholecalciferol—psoriasis	0.0633	0.0877	CbGbCtD
Dopamine—CYP2C9—Cholecalciferol—psoriasis	0.0526	0.0729	CbGbCtD
Dopamine—CYP2D6—Cholecalciferol—psoriasis	0.0481	0.0666	CbGbCtD
Dopamine—CYP2C19—Prednisone—psoriasis	0.0439	0.0608	CbGbCtD
Dopamine—CYP2C19—Cyclosporine—psoriasis	0.0416	0.0576	CbGbCtD
Dopamine—CYP2C9—Cyclosporine—psoriasis	0.0346	0.0479	CbGbCtD
Dopamine—CYP2D6—Cyclosporine—psoriasis	0.0316	0.0438	CbGbCtD
Dopamine—CYP2C19—Dexamethasone—psoriasis	0.0274	0.0379	CbGbCtD
Dopamine—CYP2C9—Dexamethasone—psoriasis	0.0228	0.0315	CbGbCtD
Dopamine—CYP2D6—Dexamethasone—psoriasis	0.0208	0.0288	CbGbCtD
Dopamine—Gangrene—Hydroxyurea—psoriasis	0.0152	0.106	CcSEcCtD
Dopamine—Gangrene—Mycophenolate mofetil—psoriasis	0.0101	0.0698	CcSEcCtD
Dopamine—Cyanosis—Acitretin—psoriasis	0.00598	0.0415	CcSEcCtD
Dopamine—Azotaemia—Cyclosporine—psoriasis	0.00423	0.0293	CcSEcCtD
Dopamine—Azotaemia—Mycophenolate mofetil—psoriasis	0.00412	0.0286	CcSEcCtD
Dopamine—Extrasystoles—Mycophenolic acid—psoriasis	0.00331	0.0229	CcSEcCtD
Dopamine—Cyanosis—Mycophenolate mofetil—psoriasis	0.0031	0.0215	CcSEcCtD
Dopamine—Mesalazine—PPARG—psoriasis	0.00305	0.661	CrCbGaD
Dopamine—Extrasystoles—Mycophenolate mofetil—psoriasis	0.00261	0.0181	CcSEcCtD
Dopamine—Necrosis—Hydrocortisone—psoriasis	0.00255	0.0177	CcSEcCtD
Dopamine—Azotaemia—Methotrexate—psoriasis	0.00234	0.0162	CcSEcCtD
Dopamine—Necrosis—Betamethasone—psoriasis	0.00218	0.0151	CcSEcCtD
Dopamine—Necrosis—Dexamethasone—psoriasis	0.00218	0.0151	CcSEcCtD
Dopamine—Atrial fibrillation—Mycophenolic acid—psoriasis	0.00213	0.0148	CcSEcCtD
Dopamine—Extravasation—Dexamethasone—psoriasis	0.00196	0.0136	CcSEcCtD
Dopamine—Extravasation—Betamethasone—psoriasis	0.00196	0.0136	CcSEcCtD
Dopamine—Necrosis—Prednisone—psoriasis	0.0019	0.0132	CcSEcCtD
Dopamine—Hypertension—Calcitriol—psoriasis	0.0018	0.0125	CcSEcCtD
Dopamine—Anxiety—Calcitriol—psoriasis	0.00176	0.0122	CcSEcCtD
Dopamine—Cyanosis—Methotrexate—psoriasis	0.00176	0.0122	CcSEcCtD
Dopamine—Angina pectoris—Mycophenolic acid—psoriasis	0.0017	0.0118	CcSEcCtD
Dopamine—Atrial fibrillation—Mycophenolate mofetil—psoriasis	0.00168	0.0117	CcSEcCtD
Dopamine—Headache—Clobetasol propionate—psoriasis	0.00168	0.0116	CcSEcCtD
Dopamine—Necrosis—Methotrexate—psoriasis	0.00159	0.011	CcSEcCtD
Dopamine—Anxiety—Acitretin—psoriasis	0.00157	0.0109	CcSEcCtD
Dopamine—Epinephrine—TNF—psoriasis	0.00156	0.338	CrCbGaD
Dopamine—Headache—Beclomethasone—psoriasis	0.00153	0.0106	CcSEcCtD
Dopamine—Headache—Fluocinonide—psoriasis	0.00151	0.0105	CcSEcCtD
Dopamine—Nausea—Beclomethasone—psoriasis	0.00145	0.01	CcSEcCtD
Dopamine—Extravasation—Methotrexate—psoriasis	0.00143	0.00989	CcSEcCtD
Dopamine—Bradycardia—Mycophenolic acid—psoriasis	0.00142	0.00987	CcSEcCtD
Dopamine—Angina pectoris—Mycophenolate mofetil—psoriasis	0.00134	0.00931	CcSEcCtD
Dopamine—Headache—Methoxsalen—psoriasis	0.00119	0.00828	CcSEcCtD
Dopamine—Nausea—Methoxsalen—psoriasis	0.00113	0.00785	CcSEcCtD
Dopamine—Bradycardia—Mycophenolate mofetil—psoriasis	0.00112	0.00779	CcSEcCtD
Dopamine—Vomiting—Calcitriol—psoriasis	0.00108	0.00749	CcSEcCtD
Dopamine—Palpitations—Mycophenolic acid—psoriasis	0.00108	0.00746	CcSEcCtD
Dopamine—Headache—Calcitriol—psoriasis	0.00106	0.00738	CcSEcCtD
Dopamine—Dyspnoea—Hydroxyurea—psoriasis	0.00106	0.00733	CcSEcCtD
Dopamine—Hypertension—Mycophenolic acid—psoriasis	0.00105	0.00729	CcSEcCtD
Dopamine—Bradycardia—Prednisolone—psoriasis	0.00105	0.00727	CcSEcCtD
Dopamine—Anxiety—Mycophenolic acid—psoriasis	0.00103	0.00716	CcSEcCtD
Dopamine—Bradycardia—Hydrocortisone—psoriasis	0.00102	0.0071	CcSEcCtD
Dopamine—Nausea—Calcitriol—psoriasis	0.00101	0.00699	CcSEcCtD
Dopamine—Tachycardia—Mycophenolic acid—psoriasis	0.000969	0.00672	CcSEcCtD
Dopamine—Bradycardia—Triamcinolone—psoriasis	0.000963	0.00668	CcSEcCtD
Dopamine—Vomiting—Acitretin—psoriasis	0.00096	0.00666	CcSEcCtD
Dopamine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000957	0.00664	CcSEcCtD
Dopamine—Headache—Acitretin—psoriasis	0.000946	0.00656	CcSEcCtD
Dopamine—Headache—Fluocinolone Acetonide—psoriasis	0.000943	0.00654	CcSEcCtD
Dopamine—Nausea—Acitretin—psoriasis	0.000897	0.00622	CcSEcCtD
Dopamine—Nausea—Fluocinolone Acetonide—psoriasis	0.000894	0.00621	CcSEcCtD
Dopamine—Dyspnoea—Mycophenolic acid—psoriasis	0.000885	0.00614	CcSEcCtD
Dopamine—Bradycardia—Betamethasone—psoriasis	0.000874	0.00606	CcSEcCtD
Dopamine—Bradycardia—Dexamethasone—psoriasis	0.000874	0.00606	CcSEcCtD
Dopamine—Hypertension—Cyclosporine—psoriasis	0.00085	0.0059	CcSEcCtD
Dopamine—Palpitations—Mycophenolate mofetil—psoriasis	0.000848	0.00589	CcSEcCtD
Dopamine—Anxiety—Cyclosporine—psoriasis	0.000835	0.00579	CcSEcCtD
Dopamine—Hypertension—Mycophenolate mofetil—psoriasis	0.000829	0.00575	CcSEcCtD
Dopamine—Anxiety—Mycophenolate mofetil—psoriasis	0.000815	0.00565	CcSEcCtD
Dopamine—Hypertension—Prednisolone—psoriasis	0.000773	0.00536	CcSEcCtD
Dopamine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000765	0.00531	CcSEcCtD
Dopamine—Bradycardia—Prednisone—psoriasis	0.000761	0.00528	CcSEcCtD
Dopamine—Hypertension—Hydrocortisone—psoriasis	0.000755	0.00524	CcSEcCtD
Dopamine—Vomiting—Hydroxyurea—psoriasis	0.000754	0.00523	CcSEcCtD
Dopamine—Headache—Hydroxyurea—psoriasis	0.000743	0.00515	CcSEcCtD
Dopamine—Anxiety—Hydrocortisone—psoriasis	0.000742	0.00515	CcSEcCtD
Dopamine—Dyspnoea—Cyclosporine—psoriasis	0.000716	0.00497	CcSEcCtD
Dopamine—Tachycardia—Prednisolone—psoriasis	0.000713	0.00495	CcSEcCtD
Dopamine—Hypertension—Triamcinolone—psoriasis	0.000711	0.00493	CcSEcCtD
Dopamine—Nausea—Hydroxyurea—psoriasis	0.000704	0.00489	CcSEcCtD
Dopamine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000699	0.00485	CcSEcCtD
Dopamine—Tachycardia—Hydrocortisone—psoriasis	0.000697	0.00483	CcSEcCtD
Dopamine—Tachycardia—Triamcinolone—psoriasis	0.000656	0.00455	CcSEcCtD
Dopamine—Hypertension—Betamethasone—psoriasis	0.000645	0.00448	CcSEcCtD
Dopamine—Hypertension—Dexamethasone—psoriasis	0.000645	0.00448	CcSEcCtD
Dopamine—Anxiety—Dexamethasone—psoriasis	0.000634	0.0044	CcSEcCtD
Dopamine—Anxiety—Betamethasone—psoriasis	0.000634	0.0044	CcSEcCtD
Dopamine—Vomiting—Mycophenolic acid—psoriasis	0.000631	0.00438	CcSEcCtD
Dopamine—Headache—Mycophenolic acid—psoriasis	0.000622	0.00432	CcSEcCtD
Dopamine—Dyspnoea—Triamcinolone—psoriasis	0.000599	0.00416	CcSEcCtD
Dopamine—Tachycardia—Betamethasone—psoriasis	0.000595	0.00413	CcSEcCtD
Dopamine—Tachycardia—Dexamethasone—psoriasis	0.000595	0.00413	CcSEcCtD
Dopamine—Nausea—Mycophenolic acid—psoriasis	0.00059	0.00409	CcSEcCtD
Dopamine—Hypertension—Prednisone—psoriasis	0.000562	0.0039	CcSEcCtD
Dopamine—Anxiety—Prednisone—psoriasis	0.000552	0.00383	CcSEcCtD
Dopamine—Tachycardia—Prednisone—psoriasis	0.000518	0.0036	CcSEcCtD
Dopamine—Vomiting—Cyclosporine—psoriasis	0.000511	0.00354	CcSEcCtD
Dopamine—Headache—Cyclosporine—psoriasis	0.000503	0.00349	CcSEcCtD
Dopamine—Vomiting—Mycophenolate mofetil—psoriasis	0.000498	0.00346	CcSEcCtD
Dopamine—Headache—Mycophenolate mofetil—psoriasis	0.000491	0.00341	CcSEcCtD
Dopamine—Nausea—Cyclosporine—psoriasis	0.000477	0.00331	CcSEcCtD
Dopamine—Nausea—Mycophenolate mofetil—psoriasis	0.000465	0.00323	CcSEcCtD
Dopamine—Headache—Prednisolone—psoriasis	0.000458	0.00318	CcSEcCtD
Dopamine—Vomiting—Hydrocortisone—psoriasis	0.000454	0.00315	CcSEcCtD
Dopamine—Headache—Hydrocortisone—psoriasis	0.000447	0.0031	CcSEcCtD
Dopamine—Nausea—Prednisolone—psoriasis	0.000434	0.00301	CcSEcCtD
Dopamine—Vomiting—Triamcinolone—psoriasis	0.000427	0.00297	CcSEcCtD
Dopamine—Nausea—Hydrocortisone—psoriasis	0.000424	0.00294	CcSEcCtD
Dopamine—Headache—Triamcinolone—psoriasis	0.000421	0.00292	CcSEcCtD
Dopamine—Nausea—Triamcinolone—psoriasis	0.000399	0.00277	CcSEcCtD
Dopamine—Dyspnoea—Methotrexate—psoriasis	0.000396	0.00275	CcSEcCtD
Dopamine—Vomiting—Dexamethasone—psoriasis	0.000388	0.00269	CcSEcCtD
Dopamine—Vomiting—Betamethasone—psoriasis	0.000388	0.00269	CcSEcCtD
Dopamine—Headache—Betamethasone—psoriasis	0.000382	0.00265	CcSEcCtD
Dopamine—Headache—Dexamethasone—psoriasis	0.000382	0.00265	CcSEcCtD
Dopamine—Nausea—Dexamethasone—psoriasis	0.000362	0.00251	CcSEcCtD
Dopamine—Nausea—Betamethasone—psoriasis	0.000362	0.00251	CcSEcCtD
Dopamine—Vomiting—Prednisone—psoriasis	0.000338	0.00234	CcSEcCtD
Dopamine—Headache—Prednisone—psoriasis	0.000333	0.00231	CcSEcCtD
Dopamine—Nausea—Prednisone—psoriasis	0.000315	0.00219	CcSEcCtD
Dopamine—Vomiting—Methotrexate—psoriasis	0.000282	0.00196	CcSEcCtD
Dopamine—Headache—Methotrexate—psoriasis	0.000278	0.00193	CcSEcCtD
Dopamine—Nausea—Methotrexate—psoriasis	0.000264	0.00183	CcSEcCtD
Dopamine—DRD2—Circadian rythm related genes—PPARG—psoriasis	0.000113	0.000875	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TAGAP—psoriasis	0.000113	0.000873	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000112	0.000871	CbGpPWpGaD
Dopamine—MAOB—Metabolism—CARM1—psoriasis	0.000112	0.000869	CbGpPWpGaD
Dopamine—DRD4—G alpha (i) signalling events—CXCL8—psoriasis	0.000112	0.000866	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—JUN—psoriasis	0.000112	0.000865	CbGpPWpGaD
Dopamine—POU5F1—Developmental Biology—IL6—psoriasis	0.000111	0.000862	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CCL20—psoriasis	0.00011	0.00085	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000107	0.000833	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—JUN—psoriasis	0.000106	0.000822	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—JUN—psoriasis	0.000105	0.000811	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CCL20—psoriasis	0.000104	0.000807	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCL20—psoriasis	0.000103	0.000798	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TAGAP—psoriasis	0.000103	0.000795	CbGpPWpGaD
Dopamine—DBH—Metabolism—PPARG—psoriasis	9.96e-05	0.000773	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CCL20—psoriasis	9.95e-05	0.000772	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HCAR2—psoriasis	9.93e-05	0.00077	CbGpPWpGaD
Dopamine—DRD3—G alpha (i) signalling events—CXCL8—psoriasis	9.92e-05	0.000769	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—TNF—psoriasis	9.83e-05	0.000762	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TAGAP—psoriasis	9.81e-05	0.000761	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—VEGFA—psoriasis	9.75e-05	0.000756	CbGpPWpGaD
Dopamine—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	9.67e-05	0.00075	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	9.63e-05	0.000747	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	9.63e-05	0.000747	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CCL20—psoriasis	9.62e-05	0.000746	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—CARM1—psoriasis	9.48e-05	0.000735	CbGpPWpGaD
Dopamine—HTR7—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	9.28e-05	0.00072	CbGpPWpGaD
Dopamine—DRD5—GPCR ligand binding—CXCL8—psoriasis	9.16e-05	0.000711	CbGpPWpGaD
Dopamine—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	8.88e-05	0.000689	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CCL20—psoriasis	8.73e-05	0.000677	CbGpPWpGaD
Dopamine—HTR1A—G alpha (i) signalling events—CXCL8—psoriasis	8.65e-05	0.000671	CbGpPWpGaD
Dopamine—SLC6A4—Circadian rythm related genes—TP53—psoriasis	8.63e-05	0.000669	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TAGAP—psoriasis	8.61e-05	0.000668	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—TNF—psoriasis	8.35e-05	0.000648	CbGpPWpGaD
Dopamine—HTR7—Circadian rythm related genes—TP53—psoriasis	8.11e-05	0.000629	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NDUFA5—psoriasis	8.01e-05	0.000622	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—JUN—psoriasis	8e-05	0.00062	CbGpPWpGaD
Dopamine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	7.99e-05	0.00062	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCL20—psoriasis	7.93e-05	0.000615	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—IL6—psoriasis	7.93e-05	0.000615	CbGpPWpGaD
Dopamine—SLC6A4—Circadian rythm related genes—IL6—psoriasis	7.9e-05	0.000613	CbGpPWpGaD
Dopamine—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	7.89e-05	0.000612	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—TP53—psoriasis	7.77e-05	0.000602	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCL20—psoriasis	7.59e-05	0.000589	CbGpPWpGaD
Dopamine—DRD2—G alpha (i) signalling events—CXCL8—psoriasis	7.59e-05	0.000589	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.47e-05	0.00058	CbGpPWpGaD
Dopamine—HTR7—Circadian rythm related genes—IL6—psoriasis	7.43e-05	0.000576	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NDUFA5—psoriasis	7.37e-05	0.000572	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NDUFA5—psoriasis	7.31e-05	0.000567	CbGpPWpGaD
Dopamine—COMT—Metabolism—CAT—psoriasis	7.27e-05	0.000564	CbGpPWpGaD
Dopamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	7.19e-05	0.000557	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—IL6—psoriasis	7.11e-05	0.000551	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—CXCL8—psoriasis	7.06e-05	0.000548	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CARM1—psoriasis	7.03e-05	0.000545	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—TP53—psoriasis	6.99e-05	0.000542	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—TP53—psoriasis	6.9e-05	0.000535	CbGpPWpGaD
Dopamine—MAOB—Metabolism—CAT—psoriasis	6.89e-05	0.000534	CbGpPWpGaD
Dopamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	6.87e-05	0.000533	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCL20—psoriasis	6.83e-05	0.00053	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CYP2S1—psoriasis	6.81e-05	0.000528	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.81e-05	0.000528	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—CXCL8—psoriasis	6.76e-05	0.000524	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCL20—psoriasis	6.74e-05	0.000523	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—IL6—psoriasis	6.74e-05	0.000523	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—IL6—psoriasis	6.4e-05	0.000496	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—IL6—psoriasis	6.31e-05	0.00049	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CYP2S1—psoriasis	6.27e-05	0.000486	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NDUFA5—psoriasis	6.24e-05	0.000484	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CYP2S1—psoriasis	6.21e-05	0.000482	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL20—psoriasis	6.14e-05	0.000477	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—CXCL8—psoriasis	6.09e-05	0.000472	CbGpPWpGaD
Dopamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	6.04e-05	0.000468	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—CXCL8—psoriasis	6.01e-05	0.000466	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CARM1—psoriasis	5.94e-05	0.000461	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL20—psoriasis	5.88e-05	0.000456	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—CAT—psoriasis	5.83e-05	0.000452	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.82e-05	0.000452	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SOCS1—psoriasis	5.66e-05	0.000439	CbGpPWpGaD
Dopamine—COMT—Metabolism—APOE—psoriasis	5.65e-05	0.000438	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CARM1—psoriasis	5.54e-05	0.00043	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—CXCL8—psoriasis	5.47e-05	0.000424	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—TYK2—psoriasis	5.4e-05	0.000419	CbGpPWpGaD
Dopamine—MAOB—Metabolism—APOE—psoriasis	5.35e-05	0.000415	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP2S1—psoriasis	5.31e-05	0.000412	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—TP53—psoriasis	5.28e-05	0.000409	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—CXCL8—psoriasis	5.23e-05	0.000406	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—CXCL8—psoriasis	5.18e-05	0.000402	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL20—psoriasis	5.16e-05	0.0004	CbGpPWpGaD
Dopamine—COMT—Metabolism—PPARG—psoriasis	4.92e-05	0.000382	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—IL6—psoriasis	4.83e-05	0.000375	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—CXCL8—psoriasis	4.7e-05	0.000365	CbGpPWpGaD
Dopamine—MAOB—Metabolism—PPARG—psoriasis	4.66e-05	0.000362	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—CXCL8—psoriasis	4.6e-05	0.000356	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—APOE—psoriasis	4.53e-05	0.000351	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SOCS1—psoriasis	4.37e-05	0.000339	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CAT—psoriasis	4.32e-05	0.000335	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SOCS1—psoriasis	4.18e-05	0.000324	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—LEP—psoriasis	4.18e-05	0.000324	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—APOE—psoriasis	4.18e-05	0.000324	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—TYK2—psoriasis	4.16e-05	0.000323	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—CXCL8—psoriasis	3.99e-05	0.00031	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—TYK2—psoriasis	3.99e-05	0.000309	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PPARG—psoriasis	3.95e-05	0.000306	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NFKBIA—psoriasis	3.89e-05	0.000302	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—CXCL8—psoriasis	3.82e-05	0.000296	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SOCS1—psoriasis	3.76e-05	0.000292	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SOCS1—psoriasis	3.71e-05	0.000288	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CAT—psoriasis	3.66e-05	0.000284	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CXCL8—psoriasis	3.62e-05	0.000281	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—TYK2—psoriasis	3.59e-05	0.000278	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.57e-05	0.000277	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—TYK2—psoriasis	3.54e-05	0.000275	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CXCL8—psoriasis	3.47e-05	0.000269	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CXCL8—psoriasis	3.44e-05	0.000267	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CAT—psoriasis	3.41e-05	0.000264	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CXCL8—psoriasis	3.39e-05	0.000263	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SOCS1—psoriasis	3.38e-05	0.000262	CbGpPWpGaD
Dopamine—MAOA—Metabolism—APOE—psoriasis	3.36e-05	0.000261	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CARM1—psoriasis	3.33e-05	0.000258	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.26e-05	0.000253	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SOCS1—psoriasis	3.24e-05	0.000251	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—TYK2—psoriasis	3.23e-05	0.00025	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—APOE—psoriasis	3.22e-05	0.00025	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—LEP—psoriasis	3.22e-05	0.00025	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TYK2—psoriasis	3.19e-05	0.000247	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CXCL8—psoriasis	3.12e-05	0.000242	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.11e-05	0.000241	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	3.09e-05	0.00024	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—TYK2—psoriasis	3.09e-05	0.000239	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—APOE—psoriasis	3.08e-05	0.000239	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—LEP—psoriasis	3.08e-05	0.000239	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CXCL8—psoriasis	3.08e-05	0.000239	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CARM1—psoriasis	3.06e-05	0.000237	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CARM1—psoriasis	3.03e-05	0.000235	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NFKBIA—psoriasis	3e-05	0.000233	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	2.96e-05	0.000229	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PPARG—psoriasis	2.93e-05	0.000227	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NFKBIA—psoriasis	2.87e-05	0.000223	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—APOE—psoriasis	2.84e-05	0.00022	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SOCS1—psoriasis	2.84e-05	0.00022	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.84e-05	0.00022	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CXCL8—psoriasis	2.81e-05	0.000218	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.78e-05	0.000216	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CXCL8—psoriasis	2.78e-05	0.000215	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—LEP—psoriasis	2.78e-05	0.000215	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—APOE—psoriasis	2.78e-05	0.000215	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—LEP—psoriasis	2.74e-05	0.000213	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—APOE—psoriasis	2.74e-05	0.000213	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—TYK2—psoriasis	2.71e-05	0.00021	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	2.69e-05	0.000208	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—APOE—psoriasis	2.65e-05	0.000205	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL6—psoriasis	2.64e-05	0.000205	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	2.6e-05	0.000201	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CARM1—psoriasis	2.59e-05	0.000201	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NFKBIA—psoriasis	2.59e-05	0.000201	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—JUN—psoriasis	2.58e-05	0.0002	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NFKBIA—psoriasis	2.55e-05	0.000198	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—LEP—psoriasis	2.5e-05	0.000194	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—APOE—psoriasis	2.5e-05	0.000194	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NFKB1—psoriasis	2.49e-05	0.000193	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PPARG—psoriasis	2.47e-05	0.000192	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TYK2—psoriasis	2.46e-05	0.000191	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.42e-05	0.000188	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—APOE—psoriasis	2.39e-05	0.000185	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—LEP—psoriasis	2.39e-05	0.000185	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CXCL8—psoriasis	2.36e-05	0.000183	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TYK2—psoriasis	2.35e-05	0.000183	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NFKBIA—psoriasis	2.33e-05	0.00018	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PPARG—psoriasis	2.31e-05	0.000179	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VEGFA—psoriasis	2.26e-05	0.000175	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—STAT3—psoriasis	2.23e-05	0.000173	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	2.23e-05	0.000173	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CXCL8—psoriasis	2.14e-05	0.000166	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TYK2—psoriasis	2.12e-05	0.000164	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—LEP—psoriasis	2.1e-05	0.000163	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APOE—psoriasis	2.1e-05	0.000163	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TYK2—psoriasis	2.09e-05	0.000162	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CXCL8—psoriasis	2.05e-05	0.000159	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CAT—psoriasis	2.05e-05	0.000159	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—psoriasis	2.04e-05	0.000158	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—JUN—psoriasis	1.99e-05	0.000154	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.95e-05	0.000152	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—psoriasis	1.95e-05	0.000151	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NFKB1—psoriasis	1.92e-05	0.000149	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—JUN—psoriasis	1.91e-05	0.000148	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TYK2—psoriasis	1.91e-05	0.000148	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CAT—psoriasis	1.88e-05	0.000146	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CAT—psoriasis	1.87e-05	0.000145	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CXCL8—psoriasis	1.85e-05	0.000143	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NFKB1—psoriasis	1.83e-05	0.000142	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TYK2—psoriasis	1.82e-05	0.000141	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCL8—psoriasis	1.82e-05	0.000141	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—psoriasis	1.75e-05	0.000136	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—psoriasis	1.74e-05	0.000135	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—psoriasis	1.73e-05	0.000134	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—psoriasis	1.72e-05	0.000134	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—JUN—psoriasis	1.72e-05	0.000133	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—psoriasis	1.7e-05	0.000132	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—JUN—psoriasis	1.69e-05	0.000131	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—psoriasis	1.66e-05	0.000129	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL8—psoriasis	1.66e-05	0.000129	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NFKB1—psoriasis	1.65e-05	0.000128	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—psoriasis	1.65e-05	0.000128	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NFKB1—psoriasis	1.63e-05	0.000126	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TYK2—psoriasis	1.6e-05	0.000124	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CAT—psoriasis	1.59e-05	0.000124	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOE—psoriasis	1.59e-05	0.000123	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL8—psoriasis	1.59e-05	0.000123	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—psoriasis	1.58e-05	0.000122	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—psoriasis	1.56e-05	0.000121	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—JUN—psoriasis	1.54e-05	0.00012	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—psoriasis	1.51e-05	0.000117	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—psoriasis	1.5e-05	0.000116	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NFKB1—psoriasis	1.48e-05	0.000115	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—psoriasis	1.48e-05	0.000115	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—psoriasis	1.48e-05	0.000115	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—JUN—psoriasis	1.48e-05	0.000114	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—psoriasis	1.46e-05	0.000114	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOE—psoriasis	1.46e-05	0.000113	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOE—psoriasis	1.45e-05	0.000112	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NFKB1—psoriasis	1.42e-05	0.00011	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL8—psoriasis	1.39e-05	0.000108	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARG—psoriasis	1.39e-05	0.000107	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—psoriasis	1.35e-05	0.000105	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—psoriasis	1.33e-05	0.000103	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—psoriasis	1.32e-05	0.000103	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—psoriasis	1.31e-05	0.000102	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—JUN—psoriasis	1.3e-05	0.0001	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—psoriasis	1.29e-05	0.0001	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—psoriasis	1.28e-05	9.9e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARG—psoriasis	1.27e-05	9.88e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARG—psoriasis	1.26e-05	9.8e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—psoriasis	1.26e-05	9.76e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NFKB1—psoriasis	1.25e-05	9.67e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOE—psoriasis	1.24e-05	9.61e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—psoriasis	1.2e-05	9.33e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—psoriasis	1.15e-05	8.93e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—psoriasis	1.13e-05	8.78e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—psoriasis	1.13e-05	8.78e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—psoriasis	1.12e-05	8.69e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—psoriasis	1.12e-05	8.67e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARG—psoriasis	1.08e-05	8.37e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—psoriasis	1.04e-05	8.04e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—psoriasis	1.02e-05	7.93e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—psoriasis	1.02e-05	7.9e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—psoriasis	9.74e-06	7.55e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—psoriasis	9.32e-06	7.23e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—psoriasis	8.91e-06	6.91e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—psoriasis	8.55e-06	6.63e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—psoriasis	7.83e-06	6.07e-05	CbGpPWpGaD
